Sabra Health Care REIT (SBRA) FY2020 results: revenue $599 million, down 9.5% on the year
Sabra Health Care REIT, Inc. (SBRA) reported revenue of $599 million for fiscal 2020, the year ended 31 December 2020, down 9.5% on the year before. Net income was $138 million, up 100.6%, and diluted earnings per share $0.67. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2021.
Revenue
$599 million
-9.5% on the year
FY2013FY2020
Operating margin
n/a
FY2013FY2020
Net income
$138 million
+100.6% on the year
FY2013FY2020
Diluted EPS
$0.67
+81.1% on the year
FY2013FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
599
662
623
-9.5%
Interest expense
100
127
147
-20.7%
Pre-tax income
156
79.2
288
+96.6%
Income tax
0.7
3.4
3.0
-79.1%
Effective tax rate
0.5%
4.3%
1.0%
Net income
138
69.0
279
+100.6%
Net margin
23.1%
10.4%
44.8%
Diluted EPS
$0.67
$0.37
$1.51
+81.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
355
372
361
-4.7%
Cash from investing
-136
263
-258
Cash from financing
-202
-646
-629
Depreciation and amortisation
177
182
191
-2.7%
Share-based compensation
7.9
9.8
7.6
-19.5%
Dividends paid
278
335
325
-17.0%
Dividend per share
$1.35
$1.80
$1.80
-25.0%
Diluted shares, weighted
207m
188m
179m
+10.2%
Shares outstanding at period end
211m
205m
178m
+2.6%
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
3,409
3,488
3,250
-2.3%
Non-controlling interest
n/a
0.0
4.3
Debt
2,372
2,402
3,232
-1.2%
Other liabilities
204
179
179
+14.1%
Total liabilities and equity
5,986
6,069
6,665
-1.4%
Intangible assets
82.8
102
131
-18.4%
Loans
n/a
63.1
69.5
Cash and equivalents
59.1
39.1
50.2
+51.1%
Other assets
5,844
5,866
6,415
-0.4%
Total assets
5,986
6,069
6,665
-1.4%
10-K for the year ended 31 December 2020, filed 22 February 2021: the filing.